Augmentation of lymphokine-activated killer cell activity in vitro by aloctin A
- 1 January 1986
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 8 (8), 855-858
- https://doi.org/10.1016/0192-0561(86)90084-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Induction of nonspecific cell-mediated cytotoxic reactivity from non-immune spleen cells treated with aloctin AInternational Journal of Immunopharmacology, 1986
- The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.The Journal of Immunology, 1985
- SUCCESSFUL IMMUNOTHERAPY OF MURINE EXPERIMENTAL HEPATIC METASTASES WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-21985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- LYMPHOKINE-ACTIVATED KILLER CELLS - LYSIS OF FRESH SYNGENEIC NATURAL KILLER-RESISTANT MURINE TUMOR-CELLS BY LYMPHOCYTES CULTURED IN INTERLEUKIN-21984
- Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.The Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.The Journal of Immunology, 1981
- Pharmacological studies on a plant lectin, Aloctin A. I. Growth inhibition of mouse methylcholanthrene-induced fibrosarcoma (Meth A) in ascites form by Aloctin ACellular and Molecular Life Sciences, 1981
- INVITRO GROWTH OF CYTO-TOXIC HUMAN-LYMPHOCYTES .4. LYSIS OF FRESH AND CULTURED AUTOLOGOUS TUMOR BY HUMAN-LYMPHOCYTES CULTURED IN T-CELL GROWTH-FACTOR1981